EE665 Cost-Minimisation Analysis of Oral Semaglutide Versus Dulaglutide in Patients With Type 2 Diabetes Requiring Treatment With a GLP-1 Receptor Agonist

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.904
https://www.valueinhealthjournal.com/article/S1098-3015(22)03108-4/fulltext
Title : EE665 Cost-Minimisation Analysis of Oral Semaglutide Versus Dulaglutide in Patients With Type 2 Diabetes Requiring Treatment With a GLP-1 Receptor Agonist
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03108-4&doi=10.1016/j.jval.2022.09.904
First page :
Section Title :
Open access? : No
Section Order : 10446
Categories :
Tags :
Regions :
ViH Article Tags :